ATORVASTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Atorvastatin patents expire, and what generic alternatives are available?
Atorvastatin is a drug marketed by Accord Hlthcare, ACI, Agnitio, Alkem Labs Ltd, Apotex Inc, Aurobindo Pharma Ltd, Biocon Pharma, Cadila Pharms Ltd, Dr Reddys, Dr Reddys Labs Ltd, Graviti Pharms, Hetero Labs Ltd V, Invagen Pharms, Lannett Co Inc, Laurus, Lepu Pharm, Lupin Ltd, Mankind Pharma, Micro Labs Ltd India, MSN, Mylan Pharms Inc, Perrigo R And D, Sandoz Inc, Sciegen Pharms Inc, Shandong Xinhua, Sun Pharm Inds Ltd, Teva Pharms, Teva Pharms Usa, Umedica, and Zydus Pharms. and is included in thirty-one NDAs.
The generic ingredient in ATORVASTATIN is atorvastatin calcium. There are sixty-two drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atorvastatin
A generic version of ATORVASTATIN was approved as atorvastatin calcium by SUN PHARM INDS LTD on November 30th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATORVASTATIN?
- What are the global sales for ATORVASTATIN?
- What is Average Wholesale Price for ATORVASTATIN?
Summary for ATORVASTATIN
| US Patents: | 0 |
| Applicants: | 30 |
| NDAs: | 31 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ATORVASTATIN |
| Drug Sales Revenues: | Drug sales revenues for ATORVASTATIN |
| DailyMed Link: | ATORVASTATIN at DailyMed |
See drug prices for ATORVASTATIN
US Patents and Regulatory Information for ATORVASTATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mankind Pharma | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 217081-004 | Jan 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Ltd | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 076477-003 | Nov 30, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Graviti Pharms | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 209912-001 | Jun 18, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cadila Pharms Ltd | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 212103-004 | Oct 16, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo R And D | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 208478-002 | Jun 23, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
